How long can I take 60 tablets of pirtobrutinib?

Pirtobrutinib (pirtobrutinib) is a new non-covalent Bruton's tyrosine kinase (BTK) inhibitor, mainly used to treat certain types of B cell malignant tumors, such as mantle cell lymphoma (MCL) and chronic lymphocytic leukemia (CLL). The drug is usually taken at a dose of 200 mg once daily, a use that has been endorsed by clinical studies and by drug regulatory agencies in multiple countries.

The common specifications of Pitobrutinib currently on the market are 100mg/ tablets. If a bottle contains 60 tablets, the total dose is 6000mg. Taking the conventional dosage of 200mg per day, 60 tablets can be used by patients for 30 days, that is, one month. If the doctor adjusts the dose based on individual circumstances (such as reducing the dose to 100 mg per day), the use of these 60 tablets may be extended to two months.

It should be noted that while using Pitobrutinib, patients should strictly follow the dosage and cycle recommended by the doctor. It is not recommended to change the dosage or stop the medication without authorization. Although the drug is designed for long-term use, patients still need to regularly monitor blood, liver and kidney function and other indicators during treatment to ensure efficacy and safety.

In addition, the price of pitobrutinib is relatively high, especially when it has not been included in medical insurance or is not yet available in the country. Some patients may purchase it through overseas channels, such as the Laos generic version, which is relatively more affordable. No matter which version is chosen, patients should ensure that the drug comes from a legitimate source and is used under the guidance of a professional doctor.

Reference materials:https://go.drugbank.com/drugs/DB17472